Goff Brian's Form 4 filing
Agios Pharmaceuticals, Inc. (AGIO) · filed Jan 2, 2026
- Accession no.
- 0001439222-26-000008
- Filed
- Jan 2, 2026
- Trade date
- Dec 30, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $506.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goff BrianCIK 0001546216 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Common stock | MOption exerciseAcquired | +25,528 | $0.00 | $0 | 149,056 | Direct | |
| Dec 30, 2025 | Common stock | SSaleDisposed | −12,473 | $27.09 | −$337,893.57 | 136,583 | Direct | |
| Dec 30, 2025 | Common stock | MOption exerciseAcquired | +12,750 | $0.00 | $0 | 149,333 | Direct | |
| Dec 30, 2025 | Common stock | SSaleDisposed | −6,230 | $27.09 | −$168,770.7 | 143,103 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Common stock | MOption exerciseDisposed | −25,528 | $0.00 | $0 | 25,528 | Direct | |
| Dec 30, 2025 | Common stock | MOption exerciseDisposed | −12,750 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.